FAS

There are 17 papers on FAS in aging research: 4 trials and 10 observational studies in people, 2 in animals, 1 review.

Biomarker

17 papers study it4 findings

See all 17 papers on FAS

“Higher pre-KT levels tumor necrosis factor receptor superfamily member 6 (FAS) and MMP-9 levels were independently associated with lower KT function one year after KT.”
Senescence Biomarkers and Trajectories of Frailty and Physical Function After Kidney TransplantationClinical transplantation2024doi:10.1111/ctr.70022
  • Human trial4
  • Humans10
  • Animals2

Interventions

2

Estradiol

downin humans1

1 study
  1. Estradiol decreases FAS in humans (compared with placebo) (-695 pg/mL (p = .036)).

    Human trialcompared with placebotransdermal36 monthsfemalesn = 34

  2. Estradiol decreases FAS in humans.

    Human trial48 months

More on Estradiol

Conjugated equine estrogens

downin humans1

1 study
  1. Conjugated equine estrogens decrease FAS in humans (−1374 pg/ml (95% CI −1940, −711)).

    Human trial48 months

More on Conjugated equine estrogens

Associations

1

Kidney transplant function

downin humans1

1 study
  1. FAS is associated with kidney transplant function in humans (pre-transplant biomarker levels in patients undergoing kidney transplantation).

    Humanspre-transplant biomarker levels in patients undergoing kidney transplantationplasma1 year after kidney transplantation61.4% malesn = 197

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 1Nov 2026: 04 papers in 12 months

See all 17 papers on FAS